Bristol-Myers Squibb Company Profile Avatar - Palmy Investing

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The compan…

Drug Manufacturers - General
US, New York [HQ]

Insiders

Transactions

Track non-derivative insider transactions.
i = Indirect d = Direct cs = Common Stock
Reported Owner(s) Position Now Transaction Date Type Position Change Extra
Holzer Phil M
SVP and Controller
$11,760 d Common Stock, $0.10 par value
10% Holder
11/04/24
S
700 x $55.62 = $38,934.00
Boerner Christopher S.
Chief Executive Officer
$104,114 d Common Stock, $0.10 par value
10% Holder
11/01/24
J
55 x $0 = $0
Boerner Christopher S.
Chief Executive Officer
$102,626 d Common Stock, $0.10 par value
10% Holder
11/01/24
F
1,488 x $54.32 = $80,828.16
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
$62,109 d Common Stock, $0.10 par value
10% Holder
11/01/24
P
1,830 x $54.67 = $100,046.10
Boerner Christopher S.
Chief Executive Officer
$104,169 d Common Stock, $0.10 par value
10% Holder
11/01/24
M
2,964 x $0 = $0

Get PRO Today

With PRO you will unlock 107 more insider transactions for Bristol-Myers Squibb Company